Panel Discussion | Challenges Designing Clinical Trials for Heart Failures Using the MCP Devices

Tuesday, February 28, 2023

8:59 AM – 9:30 AM ET

Panel Moderator(s)

KB

Keki Balsara, MD MBA FACS FACC

Surgical Director, Heart Transplantation and Mechanical Circulatory Support
Medstar Health

Disclosure(s): No financial relationships to disclose
George W. Vetrovec, MD, MACC, MSCAI

Professor Emeritus
VCU Pauley Heart Center
Richmond, Virginia, United States

Disclosure(s): Abiomed Inc: Consultant (Ongoing)

Panel Discussant(s)

William T. Abraham, MD

Professor of Medicine
The Ohio State University
Columbus, Ohio, United States

Disclosure(s): Boehringer Ingelheim: Committee/Planning Member (Ongoing); Impulse Dynamics: Consultant/Advisory Board (Ongoing); V-WAVE Medical: Salary (Ongoing), Stock-privately held company (Ongoing); Zoll Respicardia: Advisor (Ongoing)
Philip Adamson, MD, MSc, FACC, FRCP (Ed)

Chief Medical Officer and Divisional Vice President
Abbott
Austin, Texas, United States

Disclosure information not submitted.
Ori Ben-Yehuda, MD (he/him/his)

Professor of Medicine
University of California, San Diego
La Jolla, California, United States

Disclosure(s): Bioventrix, Inc: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Salary (Ongoing); Cardiovalve: Consultant (Ongoing)
David F. Kong, MD, AM, DMT (he/him/his)

Associate Professor of Medicine
Duke University
Durham, North Carolina, United States

Disclosure(s): Medtronic: University Grants/Research Support (Ongoing); Philips: University Grants/Research Support (Ongoing)
Horst Sievert, MD, FSCAI, FACC, FESC

Director
CardioVascular Center Frankfurt CVC
Frankfurt, Hessen, Germany

Disclosure(s): 4tech Cardio, Abbott, Ablative Solutions, Adona Medical, Akura Medical, Ancora Heart, Append Medical, Axon, Bavaria Medizin Technologie GmbH, Bioventrix, Boston Scientific, Cardiac Dimensions, Cardiac Success, Cardimed: Study honoraria to institution, travel expenses, consulting fees (Ongoing); Cardionovum, Celonova, Contego, Coramaze, Croivalve, CSL Behring LLC, CVRx, Dinova, Edwards, Endobar, Endologix, Endomatic, Esperion Therapeutics, Inc., Hangzhou Nuomao Medtech, Holistick Medical, Intershunt, Intervene, K2, Laminar, Lifetech: Study honoraria to institution, travel expenses, consulting fees (Ongoing); Magenta, Maquet Getinge Group, Metavention, Mitralix, Mokita, Neurotronic, NXT Biomedical, Occlutech, Recor, Renal Guard, Shifamed, Terumo, Trisol, Vascular Dynamics, Vectorious Medtech, Venus, Venock, Vivasure Medical, Vvital Biomed, Whiteswell: Study honoraria to institution, travel expenses, consulting fees (Ongoing)
Charles A. Simonton, MD, FACC, FSCAI

EVP Chief Medical Officer
Abiomed Inc
Charlotte, North Carolina, United States

Disclosure(s): Abiomed: Employee (Ongoing)
Gregg W. Stone, MD, FACC, MSCAI (he/him/his)

Physician
Mount Sinai
New York, New York, United States

Disclosure(s): Abbott, Abiomed, Bioventrix, Cardiovascular Systems Inc, Phillips, Biosense-Webster, Shockwave, Vascular Dynamics, Pulnovo and V-wave: University Grants/Research Support (Ongoing); Abiomed, CorFlow, Apollo Therapeutics, Cardiomech, Gore, Amgen, Millennia Biopharma: Consultant (Terminated); Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Cardiac Success, Valfix, Xenter: Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); Medtronic, Pulnovo, Infraredx: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Valfix, TherOx, Robocath, HeartFlow, Ablative Solutions, Miracor, Neovasc, Ancora, Vectorious, Elucid Bio, Occlutech, Impulse Dynamics, Adona Medical: Consultant (Ongoing)

Disclosure(s):

Keki Balsara, MD MBA FACS FACC: No financial relationships to disclose

George W. Vetrovec, MD, MACC, MSCAI: Abiomed Inc: Consultant (Ongoing)

William T. Abraham, MD: Boehringer Ingelheim: Committee/Planning Member (Ongoing); Impulse Dynamics: Consultant/Advisory Board (Ongoing); V-WAVE Medical: Salary (Ongoing), Stock-privately held company (Ongoing); Zoll Respicardia: Advisor (Ongoing)

Seth D. Bilazarian, MD: Abiomed Inc: Employee (Ongoing)

Ori Ben-Yehuda, MD: Bioventrix, Inc: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Salary (Ongoing); Cardiovalve: Consultant (Ongoing)

Hans R. Figulla, MD, PhD: devie medical GmbH: Officer or Board Member (Ongoing), Shareholder (Ongoing); JenaValve Technology Inc.: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Scientific Advisory Board (Ongoing); Occlutech Holding: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Shareholder (Ongoing); P+F Products and Features GmbH: Royalties (Ongoing)

James A. Goldstein, MD, FSCAI: ECLS, Inc which licenses radiation shiled technology to Image Diagnostics, Inc: Intellectual Property/Patents (Ongoing), Major Stockholder (not including mutual funds) (Ongoing), Officer or Board Member (Ongoing), Royalties (Ongoing)

David F. Kong, MD, AM, DMT: Medtronic: University Grants/Research Support (Ongoing); Philips: University Grants/Research Support (Ongoing)

Horst Sievert, MD, FSCAI, FACC, FESC: 4tech Cardio, Abbott, Ablative Solutions, Adona Medical, Akura Medical, Ancora Heart, Append Medical, Axon, Bavaria Medizin Technologie GmbH, Bioventrix, Boston Scientific, Cardiac Dimensions, Cardiac Success, Cardimed: Study honoraria to institution, travel expenses, consulting fees (Ongoing); Cardionovum, Celonova, Contego, Coramaze, Croivalve, CSL Behring LLC, CVRx, Dinova, Edwards, Endobar, Endologix, Endomatic, Esperion Therapeutics, Inc., Hangzhou Nuomao Medtech, Holistick Medical, Intershunt, Intervene, K2, Laminar, Lifetech: Study honoraria to institution, travel expenses, consulting fees (Ongoing); Magenta, Maquet Getinge Group, Metavention, Mitralix, Mokita, Neurotronic, NXT Biomedical, Occlutech, Recor, Renal Guard, Shifamed, Terumo, Trisol, Vascular Dynamics, Vectorious Medtech, Venus, Venock, Vivasure Medical, Vvital Biomed, Whiteswell: Study honoraria to institution, travel expenses, consulting fees (Ongoing)

Charles A. Simonton, MD, FACC, FSCAI: Abiomed: Employee (Ongoing)

Gregg W. Stone, MD, FACC, MSCAI: Abbott, Abiomed, Bioventrix, Cardiovascular Systems Inc, Phillips, Biosense-Webster, Shockwave, Vascular Dynamics, Pulnovo and V-wave: University Grants/Research Support (Ongoing); Abiomed, CorFlow, Apollo Therapeutics, Cardiomech, Gore, Amgen, Millennia Biopharma: Consultant (Terminated); Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Cardiac Success, Valfix, Xenter: Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); Medtronic, Pulnovo, Infraredx: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Valfix, TherOx, Robocath, HeartFlow, Ablative Solutions, Miracor, Neovasc, Ancora, Vectorious, Elucid Bio, Occlutech, Impulse Dynamics, Adona Medical: Consultant (Ongoing)